Skip to main content

Peer Review reports

From: Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)

Original Submission
15 Oct 2020 Submitted Original manuscript
26 Jan 2021 Author responded Author comments - Sander RM Bus
19 Jan 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
26 Jan 2021 Submitted Manuscript version 2
29 Jan 2021 Editorially accepted
19 Feb 2021 Article published 10.1186/s13063-021-05083-1

You can find further information about peer review here.

Back to article page